# Basaloid‐Solid Adenoid Cystic Carcinoma of the Breast: A Case Report and Literature Review

**Authors:** Yijia Zhou, Yun Hu, Yansheng Zhang

PMC · DOI: 10.1155/crip/3701240 · Case Reports in Pathology · 2026-03-03

## TL;DR

This paper reports a rare case of a breast tumor called basaloid-solid adenoid cystic carcinoma and highlights its diagnostic challenges and aggressive behavior.

## Contribution

The paper presents a new clinical case of SB-AdCC of the breast and reviews the literature to emphasize its unique features.

## Key findings

- The tumor showed distinct morphological features including solid nests of basaloid cells and cribriform areas.
- Immunohistochemical markers confirmed the diagnosis, with specific positivity for CD117, CK7, and myoepithelial markers.
- The tumor exhibited a high Ki-67 index and aggressive behavior with local recurrence and metastases.

## Abstract

Solid‐basaloid adenoid cystic carcinoma (SB‐AdCC) of the breast is a rare neoplasm. We report the case of a 78‐year‐old woman who presented with a progressively enlarging right breast mass over 3 years. Clinical examination revealed a 6‐cm mass with visible skin ulceration and right axillary lymphadenopathy. Imaging suggested malignancy, and biopsy showed a poorly differentiated tumor composed of basaloid cells arranged in solid nests with focal cribriform areas and necrosis. Immunohistochemically, the epithelial cells were positive for CD117 and CK7, whereas the myoepithelial component showed focal positivity for p63, CK5/6, and S100, and the tumor was negative for ER, PR, and HER2, with a Ki‐67 index of approximately 40%. These findings supported a diagnosis of SB‐AdCC of the breast with nodal metastasis. After multidisciplinary discussion, the patient underwent palliative mastectomy. At 12‐month follow‐up, local recurrence and bilateral axillary metastases were identified. This case emphasizes the diagnostic challenge of SB‐AdCC, its overlap with basaloid carcinoma, and the importance of recognizing its distinct morphological and molecular features.

## Linked entities

- **Proteins:** KIT (KIT proto-oncogene, receptor tyrosine kinase), KRT7 (keratin 7), RPE65 (retinoid isomerohydrolase RPE65), ck56 (hypothetical protein), S100A1 (S100 calcium binding protein A1), EREG (epiregulin), PGR (progesterone receptor), ERBB2 (erb-b2 receptor tyrosine kinase 2), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** adenoid cystic carcinoma (MONDO:0004971), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, KMT2C (lysine methyltransferase 2C) [NCBI Gene 58508] {aka HALR, KLEFS2, MLL3}, NFIB (nuclear factor I B) [NCBI Gene 4781] {aka CTF, HMGIC/NFIB, MACID, NF-I/B, NF1-B, NFI-B}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, IL9 (interleukin 9) [NCBI Gene 3578] {aka HP40, IL-9, P40}, EWSR1 (EWS RNA binding protein 1) [NCBI Gene 2130] {aka EWS, EWS-FLI1}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, MYH11 (myosin heavy chain 11) [NCBI Gene 4629] {aka AAT4, FAA4, SMHC, SMMHC, SMMS-1, VSCM2}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, CREBBP (CREB binding lysine acetyltransferase) [NCBI Gene 1387] {aka CBP, KAT3A, MKHK1, RSTS, RSTS1}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, MYB (MYB proto-oncogene, transcription factor) [NCBI Gene 4602] {aka Cmyb, c-myb, c-myb_CDS, efg}
- **Diseases:** triple (MESH:C536008), bleeding (MESH:D006470), lymphadenopathy (MESH:D008206), stroke (MESH:D020521), carcinoma (MESH:D009369), AdCC of (MESH:D003528), SB-AdCC of the breast (MESH:D005348), necrosis (MESH:D009336), triple-negative breast cancer (MESH:D064726), SB-AdCC of the breast (MESH:D001943), axillary lymph node metastases (MESH:D008207), metastases (MESH:D009362), Basaloid (MESH:C565284), Breast (MESH:D061325), hypertension (MESH:D006973)
- **Chemicals:** H&amp;E (MESH:D006371)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** AdCC — Homo sapiens (Human), Salivary gland adenoid cystic carcinoma, Cancer cell line (CVCL_C4UW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12954464/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12954464/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12954464/full.md

---
Source: https://tomesphere.com/paper/PMC12954464